The impact of AI and ML on the future of drug discovery
Over the past several years, Dr Jo Varshney, Founder of VeriSIM Life, has front-led numerous collaborative engagements with a host of biopharma companies, government agencies, academic/medical institutes and industry innovators. Here, she discusses with DDW’s Megan Thomas the impact of AI and ML on the drug discovery process. MT:… Read More